From Our Partners
Saturday, June 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

NIAID Adjuvant Discovery Program

by Global Biodefense Staff
May 13, 2013

Laboratory ResearchThe National Institute of Allergy in Infectious Diseases has renewed a Broad Agency Announcement (BAA) to provide support for the early stage discovery and initial characterization of novel adjuvant candidates.

Research solicited under this acquisition will contribute to the pipeline of new adjuvant leads that either exploit the natural capacity of the innate immune system to initiate and sustain effective T and B cell responses and to induce long term immune memory or act directly on lymphocytes to enhance their response to pathogen-derived antigens.

The design of new adjuvants in this program must include each of the following areas of research:

Identification of novel adjuvant candidates through High Throughput Screening (HTS) approaches and validation that lead compounds stimulate human cells
Determination of the mechanism of action of select lead compounds, including the identification of the receptors the adjuvant candidates work through and the cellular signaling pathways they activate
Optimization of lead adjuvant candidates through formulation and medicinal chemistry, guided by structure-activity relationship (SAR) studies
Verification of the efficacy of lead compounds as vaccine adjuvants in vivo in an animal model

The government anticipates that multiple awards will be made from this solicitation in September 2014.

Further details are available under Solicitation Number: BAA-NIAID-DAIT-NIHAI2013168. The response deadline is October 24, 2013.

From Our Partners
Tags: Animal ModelsBAA

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents
CBRNE

Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents

April 11, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC